Cargando…
Dimethyl Itaconate Reduces α-MSH-Induced Pigmentation via Modulation of AKT and p38 MAPK Signaling Pathways in B16F10 Mouse Melanoma Cells
Dimethyl itaconate (DMI) exhibits an anti-inflammatory effect. Activation of nuclear factor erythroid 2-related factor 2 (NRF2) is implicated in the inhibition of melanogenesis. Therefore, DMI and itaconic acid (ITA), classified as NRF2 activators, have potential uses in hyperpigmentation reduction....
Autores principales: | Jang, Sungchan, Chi, Won-Jae, Kim, Seung-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268225/ https://www.ncbi.nlm.nih.gov/pubmed/35807430 http://dx.doi.org/10.3390/molecules27134183 |
Ejemplares similares
-
Dimethyl Itaconate Inhibits Melanogenesis in B16F10 Cells
por: Yu, Bo-Yeong, et al.
Publicado: (2023) -
Tobramycin Promotes Melanogenesis by Upregulating p38 MAPK Protein Phosphorylation in B16F10 Melanoma Cells
por: Moon, Seung-Hyun, et al.
Publicado: (2019) -
Inhibitory Effect of Elaeagnus umbellata Fractions on Melanogenesis in α-MSH-Stimulated B16-F10 Melanoma Cells
por: Lee, Ji-Hyun, et al.
Publicado: (2021) -
Soyasaponin Ag inhibits α-MSH-induced melanogenesis in B16F10 melanoma cells via the downregulation of TRP-2
por: Yang, Seung Hwan, et al.
Publicado: (2017) -
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis
por: Kuo, Ping-Chang, et al.
Publicado: (2020)